Clinical trials
Pathologic Processes trials in the United States with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
30 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2013 | 2 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 3 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 5 |
| 2025 | 5 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 18 |
| Recruiting | 10 |
| Active, not recruiting | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Brigham and Women's Hospital | 2 |
| Medtronic Cardiac Ablation Solutions | 2 |
| University of Pittsburgh | 2 |
| University of Texas at Austin | 2 |
| Washington University School of Medicine | 2 |
| Benaroya Research Institute | 1 |
| C5 Biomedical | 1 |
| Carol Fabian, MD | 1 |
| Coloplast A/S | 1 |
| Duke University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pathologic Processes | 30 |
| Cardiovascular Diseases | 8 |
| Arrhythmias, Cardiac | 6 |
| Brain Diseases | 6 |
| Central Nervous System Diseases | 6 |
| Heart Diseases | 6 |
| Nervous System Diseases | 6 |
| Vascular Diseases | 6 |
| Atrial Fibrillation | 3 |
| Cerebrovascular Disorders | 3 |
Trials
Showing 1 to 25 of 30. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.